Human-engineered heart tissues recapitulate tissue-scale mechanisms underlying ventricular tachycardia

This study demonstrates that human iPSC-derived engineered heart tissues, when coupled with a novel high-resolution optical mapping workflow, successfully recapitulate the tissue-scale mechanisms of ventricular tachycardia associated with acquired long QT syndrome—including action potential dispersion, conduction block, and reentry—thereby providing a scalable, non-animal platform for mechanistic arrhythmia research.

The Gist

Imagine your heart as a bustling city where electricity is the traffic system, keeping everything running smoothly. Sometimes, this traffic gets chaotic, leading to a dangerous condition called Ventricular Tachycardia (VT), where the heart beats too fast and irregularly, like a city gridlock that never clears.

For a long time, scientists could only study this chaos in animal hearts or human hearts that had already been removed from the body. They wanted to see how the traffic jams formed, but they lacked a small, manageable "mini-city" to test their theories on.

Here is what this new study did, explained simply:

1. Building a Mini-Heart City

The researchers built tiny, artificial hearts using human stem cells (think of them as "seed cells" that can turn into heart muscle). They shaped these cells into small, living tissues called Engineered Heart Tissues (EHTs).

To watch these mini-hearts work, they invented a special camera system. Imagine a high-speed drone flying over a city at night, taking pictures so fast and clear that you can see every single car (or in this case, every electrical spark) moving. This camera could see the electrical signals and the calcium levels (the fuel for the muscle) with incredible detail.

2. Creating the Perfect Storm

To see if these mini-hearts could actually get sick, the researchers tried to recreate the conditions that cause heart attacks in real life. They did two things:

• Blocked a safety valve: They used a drug to block a specific channel (hERG) that helps the heart reset after a beat.
• Removed the fuel: They lowered the levels of potassium and magnesium (electrolytes), which are like the oil and gas that keep the engine running smoothly.

In the real world, this combination is a recipe for disaster. In their mini-hearts, it worked exactly the same way. The "healthy" mini-hearts kept a steady rhythm, but the "sick" ones started having wild, chaotic bursts of beating.

3. Watching the Traffic Jam Form

This is the most exciting part. The researchers didn't just see the heart beating fast; they saw why it was beating fast. Using their high-speed camera, they watched the electrical waves travel through the tissue like a wave moving through a stadium crowd.

Here is what they found happening inside the "sick" mini-hearts:

• The Long-Short Gap: Some parts of the heart were taking too long to reset (long), while others were resetting too quickly (short). Imagine a group of runners where some are sprinting and others are walking; they can't stay in sync.
• The Wall of Silence: Because of this mismatch, the electrical wave hit a patch of tissue that was still "asleep" (refractory) and couldn't pass through. This created a conduction block, like a road closed for construction.
• The Spin: When the wave hit this dead end, it didn't just stop; it got stuck spinning around the blockage, creating a rotor. Think of it like a car getting stuck in a roundabout, spinning in circles and causing a massive pile-up behind it.
• The Spark: Sometimes, the heart muscle would get a little "jolt" before it was ready to fire again (called an early afterdepolarization), acting like a spark plug firing at the wrong time, starting a new fire.

4. Why This Matters

Before this study, scientists could only see these spinning "rotors" and chaotic waves in whole animal hearts or human hearts. Now, they can see the exact same mechanisms happening in a tiny, human-made tissue in a dish.

The Big Takeaway:
This study proves that we can now use human-made mini-hearts to study dangerous heart rhythms without needing animals. It's like having a perfect, miniature simulation of a city's traffic grid. We can test new drugs to fix the "traffic jams" or understand exactly why the gridlock happens, all in a small, controllable, and ethical way.

In short: They built a tiny human heart, broke it on purpose to mimic a real heart attack, and used a super-camera to watch the electrical chaos unfold, proving that these mini-hearts behave just like the real thing.

Technical Summary

Technical Summary: Human-Engineered Heart Tissues Recapitulate Tissue-Scale Mechanisms Underlying Ventricular Tachycardia

1. Problem Statement

While human induced pluripotent stem cell-derived engineered heart tissues (EHTs) and cardiac organoids are widely utilized for modeling cardiac physiology and drug responses, a critical gap remains: it is unclear whether these models can reproduce tissue-scale mechanisms underlying ventricular arrhythmias, specifically ventricular tachycardia (VT).

The primary technical bottleneck has been the lack of a recording framework compatible with small, perfused EHT preparations. Although high-resolution mapping hardware exists, it has not been effectively coupled with EHT fabrication to allow for the simultaneous, high-fidelity recording of voltage and calcium dynamics necessary to study complex arrhythmic phenomena like reentry and wavebreak.

2. Methodology

The authors developed a reproducible workflow integrating advanced fabrication with high-resolution optical mapping:

• Fabrication: Utilization of milliPillar-based EHT fabrication to create small, perfused tissue preparations.
• Optical Mapping System: Implementation of a dual-channel optical mapping system with high spatiotemporal resolution:
  • Spatial Resolution: 22 µm.
  • Temporal Resolution: 1 ms.
  • Fluorescent Probes: Simultaneous recording of membrane voltage using RH-237 and intracellular calcium ($Ca^{2+}$) using Rhod-2 AM.
• Experimental Groups:
  • Baseline/Control: Standard field stimulation to establish physiological benchmarks.
  • Pharmacological Validation: Selective hERG blockade using E-4031 to confirm drug sensitivity.
  • VT Induction (Proarrhythmic Perturbation): A combination of hERG inhibition (mimicking Long-QT syndrome) with hypokalemia and hypomagnesemia. This electrolyte disturbance profile mimics common clinical conditions known to trigger acquired Long-QT syndrome and arrhythmias.

3. Key Contributions

• Technical Integration: Successfully coupled milliPillar-based EHTs with dual-channel optical mapping, overcoming previous limitations in recording small, perfused cardiac tissues.
• Mechanistic Validation: Demonstrated that human iPSC-derived EHTs can recapitulate complex, tissue-scale arrhythmic mechanisms previously only observable in intact animal hearts or human hearts.
• Scalable Non-Animal Platform: Established a scalable, human-relevant system for mechanistic arrhythmia research that reduces reliance on animal models.

4. Key Results

Baseline and Pharmacological Validation:

• EHTs exhibited physiological behaviors consistent with published human and animal data, including rate-dependent restitution of Action Potential Duration (APD) and Calcium transient duration (CaD), conduction slowing at high pacing rates, and normal AP-Ca$^{2+}$ activation latency.
• Treatment with E-4031 successfully prolonged APD, confirming the model's pharmacological sensitivity.

VT Induction and Electrophysiological Dynamics:

• Contractile Behavior: Treated EHTs displayed tachyarrhythmic contractile bursts with significant beat-to-beat instability, contrasting with the synchronous response of controls.
• Spatiotemporal Dynamics:
  • Dispersion: Progressive shortening of diastolic intervals and the emergence of APD dispersion characterized by transient, localized "long-short" APD zones.
  • Conduction Barriers: Regional depression of excitability created spatial conduction barriers, leading to wavebreak and reentry.
  • Triggered Activity: Early Afterdepolarizations (EADs) contributed to triggered activity, creating localized repolarization barriers that facilitated rotor formation.
• Rotor Characterization:
  • Phase singularity tracking identified short-lived rotors predominantly localized in the "heads" of the VT EHTs.
  • A minority of tissues exhibited multiple simultaneous rotors and wavelets, generating chaotic-like activation patterns.
• Phenotype Specificity: While tissue acceleration promoted rotor formation, the events were brief due to the spatial constraints of the EHTs. The resulting phenotype more closely resembled Ventricular Tachycardia (VT) rather than Torsades de Pointes or sustained fibrillation.

5. Significance

This study provides definitive evidence that human iPSC-derived EHTs are capable of modeling tissue-scale mechanisms of ventricular arrhythmias associated with acquired Long-QT syndrome. Specifically, the platform successfully reproduces:

• APD dispersion with long-short zones.
• Triggered activity and EADs.
• Conduction block and wavebreak.
• Reentry and rotor formation.

By bridging the gap between cellular-level models and intact heart physiology, this platform offers a scalable, non-animal system for investigating the complex mechanisms of arrhythmias and testing anti-arrhythmic therapies with higher physiological relevance than previous in vitro models.